• Results
  • Key Finding: Adaptations to existing vaccines account for...
Key Finding

Adaptations to existing vaccines account for half of vaccine R&D projects

The 2017 Access to Vaccines Index has evaluated the pipelines of eight vaccine companies: Daiichi Sankyo, GSK, Johnson & Johnson, Merck & Co., Inc., Pfizer, Sanofi, Serum Institute of India and Takeda. The industry is responding to cases where existing vaccines need to be adapted: such projects account for 48% of projects in the pipeline (43/89), with one project aiming for multiple adaptations.

Explore further

Back to top |